I t was developed in the early 1940s for the prophylaxis and treatment of malaria. The dosage for prophylaxis is 500 mg per week, and for treatment i t is an initial 500 to 1000 mg, followed by 500 mg per day for 2 to 3 days, an8 then 500 mg per week (22) .
Since the early 1950s, chloroquine has been used extensively for the prolonged treatment of a variety of chronic diseases i n human beings, such as: rheumatoid a r t h r i t i s (f,8,9,14,22,47 ,67,75,97,98,~05~, (71). granuloma a n u l a r e ( 7 ' l ) , dermal l i g h t sensitivity (141, a n d amoebiasis (57,671. The dosages required for the treatment of such chronic diseases have ranged from 250 to 1000 mg per day for periods of several months to 10 years and have been massive compared to the dosages employed for the prophylaxis or treatment of malaria (5, 6, 9, 13, 22, 26, 31, 37, 67, 71, 76, 80, 98, 103) .
During therapy, chloroquine and i t s metabolite desethylchloroquine accumulate in the tissues of the body, with the greatest concentrations occurring in the pigmented uveal tract, kidney, lung, liver and spleen (10, 14, 26, 62, 77, 86) . When massive doses have been administered, these residues may be detected in some tissues for up to 5 years after the discontinuance of therapy (26) . As demonstrated with mice (95). rabbits (14), rats (14, 60, 61) , and wine (38), chloroquine and its metabolite have a special affinity for melanin (87) and accumulate in high concentrations in the pigmented uveal tract. They may be detected in this location long after the discontinuance of medication (38) when other tissue levels have been depletedl1 4,105).
Following the admin~stration of one 0.1to 1.0-g dose, chloroquine and i t s metabolite may be found in the blood and urine o f human beings f o r a t least 1 0 days ',post-medication (1 4.35.56) . In instances where massive doses have been administered for prolonged periods of time, traces can be found in the blood and urine for several years after the di~ontinuance of therapy (26, 86) .
Since the advent of the use of chloroquine in the treatment of chronic diseases, several reports have appeared in the literature which have attributed a dosedependent, reversible, degenerative myopathy of cardiac, skeletal, and smooth muscle to the prolonged administration of massive doses to human beings (9, 24, 80, 99) , rats (43, 45, 68) , and swine (37,811. It has been postulated that the myopathy results from the inhibition of glycogenolytic enzyme(s) by chloroquine (24) . Histologically, the myopathy has been characterized by variable degrees of intensity of a Combination of deviations from normal morphology such as loss of striations, vacuolation of fibers, swelling of fibers, necrosis of fibers, hypcrplasia of sarcolemmal nuclei, fibrosis, and granulomatous inflammation (9, 24, 37, 45, 68, 81, 99) .
Necrosis of lymphatic tissues with loss of lymphocytes and a marked proliferation of reticuloendothelial cells has been observed as a dose-dependent effect in the spleen, lymph nodes, and lymphoid aggregates of the intestinal tract of swine which have received massive doses of chloroquine for prolonged periods of treatment (37). In the same study, a dosedependent degenerative change occurred in the neurons of the brain and spinal cord, the ganglion cells in different organs, the spinal nerve ganglia, and the retina. The change in both neurons and ganglion cells was characterized by cytoplasmic swelling, severe loss of Nisi substance, and a lipid or pseudolipid dystrophy which resulted in a foamy appearance of the cytoplasm (37, 38, 81) .
Numerous reports have appeared in the literature which have described the signs and symptoms of ocular toxicity attributed to the p r o l o n~d administration of massive doses of c h l o r o q u i n e t o human beings (5,6,8,9-13, 15,16, 80,82,84,86,90-92,98,101,103,104). Such ocular toxicity has been manifested as corneal keratopathy (l5,22,26,47,67,70, 73,73,91,98,104] ; myopathy of the ciliary (22,71.801 and extraocular rectus (80) muscles; paresis of the ocular muscle (71); variable defects in vision such as defective color vision(26,27,70,98),abnormal electroretinograms(26,31,41,48, 50,70,84,98) , impaired central vision (1 3,26,47-50,67,70,98) , peripheral constriction of the visual field, and a multiplicity of retinal changes such as constriction and attenuation of the v a s c u l a t u r e f 1 3 , 2 6 , 4 7 -5 0 , 6 7 , 7 0 , 9 8 , 1 0 3 ) , edema (47-49,70,98,103~, fluorescent granular deposits of the drug (42, 98, 103) , atrophy, and pigmentary changes of the macula (13, 22, 26, (46) (47) (48) (49) (50) 67, 70, 75, 98, 103) . Most of these toxic effects are not observed if the dosage i s kept under 250 mg per day, even when the drug i s administered for prolonged periods of therapy (1 1,12,22.26,71 1. At one time it was thought that the ocular changes caused by prolonged therapy with massive doses of chloroquine were reversible upon the discontinuance of therapy (5, 9, 20, 71 ) .The drug-induced keratopathy i s reversible within a few weeks of the termination of prolonged treatment with the drug (1 5,22,37,47,67,98,104) .lf the retinopathy is recognized in its very early stages and treatment is immediately discontinued, it may be reversible (22'26) . However, in cases of prolonged therapy with massive doses, the retinopathy is apparently irreversible and progressive after the termination of treatment (22,26,37,40,47-49,67,70.73,81,98,103) .
Five reports have appeared in the literature dealing with the histopathologic examination of the eyes of three human 20, 22, 26, 27, 31, 36, 39, 40, [46] [47] [48] [49] 59, 67, [69] [70] [71] [73] [74] [75] [76] , p a t i e n t s w h o w e r e a f f e c t e d b y c h l o r o q u i n e retinopathy (1 3,14,67,80,98) . In t w o instances, destruction of the rods and cones was described (l3,14,98) ; and in the third instance, the retina was described only as being disorganized and destroyed (67). In all three instances, there was a redistribution (migration) of pigment or pigment-laden cells within t h e various layers of the retina (13, 14, 67, 98) . In one instance, the pigment epithelium itself appeared normal (98). The fourth report dealt with the re-examination of the eyes of one patient by means of electron microscopy (80).
Chloroquine retinopathies have been experimentally induced in unmated (42,43), pregnant(95) , and fetal mice(95); pigmented (1, 2, 14, 42, 43, 50) and albino rats (1, 2, 14, 32, 33, 42, 43, 50, 60, 61) ; pigmented and albino rabbits (14,19,34,64); cats(42,43,63,65); dogs (42,431; and swine (37,38,81) . The dosages, route of administration, and dufation of medication employed in such studies have varied considerably as shown by t h e selected examples in Table 1 . In all animals, with the exception of the albino rabbit (14), it has been reported that the drug concentrates in ocular tissues within. several hours after the administration of the first dose, and that greater concentration occurs in pigmented a s compared to albino animals (13, 14, (32) (33) (34) 38, 60, 61, 65, 95, 105) . The increased concentration of the drug in the retina of pigmented animals is thought to be related to the affinity of chloroquine for melanin (4.1 3,14,41,77-79,87,95) . Several postulations have been made relative t o the affinity of the drug for melanin and the pathogenesis of the drug-related retinopathy. It has been demonstrated that chloroquine reacts strongly with nucleic acids and nucleoprotein (17.72) and that it can inhibit the incorporation of amino acid into protein (41, 58, 85) . On t h e basis of such data, it has been suggested that two factors are possibly involved in chloroquine retinal toxicity: (A) a high local concentration of t h e drug over a long period of time due to absorption on melanin granules and its gradual elution into the cytoplasm of the retinal pigment epithelial cell, and (B) t h e exertion of toxicity by the inhibition of proteinsynthesis in the cell (41). Athird explanation that has been offered is that t h e retinopathy is due to an adverse effect of chloroquine on the specific permeability of the retinal pigment epithelial cell(65). It has also been demonstrated that chloroquine can inhibit a variety of enzymes (13, 21, 24, 66, 87, 102) and result in a n i m p a i r m e n t o f t h e digestive capacity of lysosornes (l,3,97) . It has been postulated that since lysosomes are involved in the degradation of melanin granules(52), their impairment by chloroquine may lead to an increase and accumulation of melanin within t h e retinal pigment epithelium with secondary degeneration of the layer of rods and cones(1). A fourth postulation that has been offered is that in the melanocytes of the retinal pigment epithelium, enzyme activity, protein synthesis and protein binding to melanin may be reduced by chloroquine, resulting in the formation of protein-deficient melanin which contains a high concentration of the drug and is unable to provide protection against light-induced darnage(87).
All of the postulations which have been offered for the pathogenesis of chloroquine retinopathy would support the histopathologic changes that have been described for the lesions observed in human patients (1 3,14,67,80,98) . The histopathologic changes observed in experimental animals which have received massive doses of the drug for prolonged periods of time are more variable than those which have been d e s c r i b e d in t h e literature for the three human patients (l3,14,67,80) . In mice which received 1 0 0 mg per kg per day for 1 1 m o n t h s , t h e o n l y c h a n g e s n o t e d w e r e refractile intracytoplasmic granules (inclusions) in some of the ganglion cells of the ganglion cell layer and an apparent reduction in t h e cell population of the outer nuclear layer a t the periphery of the retina (43). Several reports in the literature (1,501 cite changes a s having been described as occurring in the retina of pigmented and/or albino rats when in fact the cited article described only t h e histologic observations noted in a human patient (14) . Early changes noted in both pigmented and albino rats after 3 to 7 months of medication have consisted of swelling (edema) of the ganglion cells of the ganglion cell layer and t h e presence of g r a n u l a r i n t r a c y t o p l a s m i c inclusions within these cells ( 1, (32) (33) (34) 43, 50) . Similar inclusions were observed in a few bipolar cells of the inner nuclear layer and in some dendrites within the inner plexiform layer(l,43) and occasionally within cells in the nerve fiber layer, outer nuclear layer, and outer p l e x i f o r m l a y e r s (1, (32) (33) (34) 50) . These intracytoplasmic inclusions were characterized as being slightly refractile, staining orthochromatically with toluidine blue, exhibiting sudanophilia, staining positively with Baker's acid hematin, a n d a s s o c i a t e d w i t h sites of a c i d phosphatase activity (1, 4, 43, 50) . The nuclei of Miller fibers within t h e inner nuclear layer were observed t o be hyperchromatic and, in pigmented rats, such nuclei were also observed in the inner plexiform layer(43). In t h e pigmented rat, degeneration of the visual cells of the outer nuclear layer was observed and was described as being more marked a t the retinal periphery(43). The visual cells were characterized as being unaffected in the albino rat(43) and, in both the pigmented and albino rat, t h e p i g m e n t e p i t h e l i u m , Bruch's membrane, and the choriocapillaris were found to be unaffected (43,501. As the retinopathy prGgressed, degenerative changes affected all cell layers of t h e retina. The outer plexiform layer virtually disappeared, the outer nuclear layer was atrophied and merged with the inner nuclear layer, the layer of rods and cones was atrophied, and some of the pigment epithelial cells were swollen (32-34,43). lntracytoplasmic inclusions had been observed in treated rats in cells in all layers of t h e retina i n c l u d i n g t h e M i i l l e r f i b e r s a n d p i g m e n t epithelium (32) (33) (34) 43, 50) . Migration of t h e retinal pigment e p i t h el i a I c el Is ( 3 2 -3 4 ) , c a p i l l a r y e n d o t h e l i a l hyperplasia (32-34). and chloridal sclerosis (32-34,43) have also been observed.
No retinal changes detectable by bright-field microscopy have been observed in albino rabbits which have received chloroquine a t dosage levels which have been retinotoxic for pigmented rabbits (19) . In pigmented rabbits, the retinopathy has been characterized by thickening of the pigment epithelial cell layer (64),atrophy of t h e rods and cones, and migration of melanin to other layers of t h e retina (19, 34, 64) .
One report in the literature(1) cites changes as having been described as occurring in t h e retina of t h e cat when in fact the cited article described only the histologic observations noted in a human patient (14). Refractile, orthochromatic, granular, intracytoplasmic inclusions have been observed in the ganglion and bipolar cells of the retina of cats which have received chloroquine(43). The inclusions were also observed in the axons of ganglion cells within the inner plexiform, inner nuclear, and outer nuclear layers(43). In one study, the layer of rods and cones and the pigment epithelium were not affected by the drug(43).ln contrast, thickening of the pigment epithelial cell layer with centripetal migration of melanin and atrophy of the layer of rods and cones has also been described (63-65).
I n chloroquine-treated dogs, intracytoplasmic, orthochromatic inclusions similar to those described for mice, rats, rabbits, and cats have been observed in the ganglion cells of the ganglion cell layer of the retina and their dendrites within the inner plexiform layer and in bipolar cells in the outer nuclear membrane(43). in addition, round eosinophilic bodies, thought t o represent netrotic bipolar cells, were observed in the outer plexiform layer. Cytoplasmic swelling and granulation were noted in the outer nuclear layer of the peripheral retina, and unspecified degenerative changes were noted in the layer of rods and cones. No abnormalities were noted i n the pigment epithelium or Bruch's membrane.
Intracytoplasmic, orthochromatic inclusions have also been observed i n the ganglion cells of the ganglion cell layer of the retina of chloroquine-treated swine (37, 38) . In addition, the ganglion cells were described as being swollen, devoid of Nisst substance, pale in tintorial qualities, and foamy in appearance. Edema was noted in the interstitium of the adventitia of veins jutting into the vitreous, beneath the inner limiting membrane, and in the ganglion cell and nuclear layers. Round, eosinophilic, extracellular bodies which were described as resembling Councilman bodies, and being similar to those described for the dog(43), were present in the outer plexiform layer. These were thought to be products of degeneration. In some animals, collections of small eosinophilic hyaline, membrane-bound, intracellular bodies were observed in the outer plexiform layer a t the edge of the inner nuclear layer. These bodies stained blue with lux01 fast blue, were interpreted as degeneration products within macrophages(37), and were thought to be associated with edema (38) . No abnormalities were noted in the pigment epithelium.
U1tra;tructural studies have been performed on the retinas of chloroquine-treated mice(43), r a t d l ,2,42,43,50), cats (431, dogs(431, swine(38,81) , and a human being(80) in order to characterize the microscopic changes noted in the previously cited studies. On examination with the electron microscope, in all animal species the intracytopfasmic granular inclusions observed in the retina by bright-field microscopy were seen as oval or round structures, measuring 0.2 to 2.0 ,urn (38, 43, 50) . These structures were designated as myeloid( I ,80) or membranous cytoplasmic bodies(MCB) (50, 80, 81) .
MCBs have been characterized as consisting of variable numbers of electron-dense, osmiophilic membranes composed of two adielectronic layers separated by a dielectronic region(43). These unevenly spaced membranes were observed to be arranged in closely applied layers in a concentric lamellar pattern around a homogenous or finely granular central zone (CZ)(43,50). The larger MCBs were observed to possess numerous layers of laminated membranes while the smallest possessed only two laminated membranes(43). In the latter, a dense line was observed where the membranes are in contact; and in the larger MCBs, such dense lines occurred at a regular periodicity with a mean of 4.3nm(43). The dense line was observed to be lost where two membranes bifurcate, and to reappear where they re-establish contact with adjacent layers.
A few MCBs were described as compou~d structures with laminations surrounding two or more CZs(43).
In addition to whorled MCBs as previously described, other patterns have been observed. In mice the CZ is reported to be larger than observed in rats and dogs, and lamellation is confined to a relatively narrow outer band(43). A second form, which i s frequently membrane bound, has been observed in cats (43). It is composed of lamellae arranged in parallel stacks. Transitional forms between MCBs and curvilinear tubules have been observed in the human being(80).
MCBs have been observed in all cell layers of the retina of chloroquine-treated subjects but are most prominent within the ganglion and bipolar cells ( I ,2,38,42,43,50,80) . They have been variously described as occurring in clusters in the perikaryon d o s e t o the nucleus (50), in close proximity to the Golgi apparatus (431, or in the vicinity of the rough endoplasmic reticulum(43). There is some variance of opinion in the literature as to whether MCBs are (1, 43, 81) or are not(43,80) membrane bound. Normal lysosomes are decreased in number or are absent from the ganglion cells of chloroquine-treated animals(43). Some investigators have expressed the opinion that MCBs are altered lysosomes (l,81) . This is based on the observation that, when stained by techniques for the demonstration of sites of acid phosphatase activity, the product of the reaction is partially localized within MCBs(l,81). Lysosomes, melanosomes, and the Golgi zone of retinal cells have been reported to yield a strong positive reaction for acid phosphatase; and in some instances, the endoplasmic reticulum has also been .observed to contain sites of acid phosphatase activity(l,4).
In addition t o the retina, MCBs have been observed in numerous other tissues of chloroquine-treated animals, In rats, they have been described as occurring in the liver(3,2a), heart (45), chromaffin cells of the adrenal medullaf43), leukocytes(29), and pancreatic exocrine cells(29). They have also been observed in neurons within a dorsal root ganglion of a dog(43). However, the most thorough description of their distribution occurred in studies in which swine were utilized(37,81). In the latter species, they have .been observed i n the following sites: neurons of the brain and spinal cord (37,81);, astrocytes and microglial cells of the central nervous system (81); ganglion cells of the peripheral nervous system (37,811; cardiac, skeletal, and smooth muscle fibers(81); endothelial cells and pericytes of all vascular c o m P O n e n t s ( 8 7 1 ; I eukocytes (81); reticuloendothelial cells and macrophages within the spleen, lymph nodes, intestine, and liver(81); myoepithelial cells of the submandibular salivary gland(81); interstitial fibroblasts in several organs(81); and hepatic, pancreatic, adrenal cortical, biliary ductal, pancreatic ductal, bronchial, bronchiolar, alveolar, salivary gland acinar, salivary gland ductal, thyroid acinar, duodenal mucosal, and renal ductal epithelial cells(81). I n swine, in most instances, the MCBs were described as being membrane bound(8~). MCBs have also been observed within leukocytes o f human beings(28) and in cultured macrophages(30) which have been treated with chloroquine.
The MCBs observed in the retina and other tissues of chloroquine-treated animals have been described as being morphologically similar ( 1, 37, 38, 42, 43, 50) to the laminated membranous cytoplasmic inclusions which have been described as occurring in human beings afflicted with Tay-Sach's disease (88,93,95a,96) ; dystonic juvenile idiocy w i t h o u t amaurosis(25); Farber's disease(l8f; and Niemann-Pick disease(l8). c i r c u i a t i n g Vol. 111, No. 3, September 1975
Considerable information has been reported in the literature relative to the dosage and duration of the period of administration of chloroquine which is required to produce MCBs in the retina of various species of laboratory animals. In a study in which chloroquine phosphate was administered to both albino and pigmented rats in their drinking water, rats which received 0.4 mg per ml of water per day for 7 consecutive months had numerous MCBs in retinal ganglion cells and to a lesser extent within the cells of all neural elements of the retina(50). In this Same study, fewer MCBs were observed in the retinas of rats which received 0.8 mg per ml of water per day for between 2 weeks and 2 months. All of the rats in this dose group died by the end of the second month of the study. Similarly, rats which received 1.6 mg per ml of water per day in this same study died during the first two weeks of medication. In the latter group, MCBs were not observed in the retina. However, only the tissues of 1 rat in this group were suitable for electron microscopy. In all dose groups in the study, the pigment epithelium of the retina was unaffected by the administration of chloroquine.
In another study, mice, albino and pigmented rats, cats, and dogs received chloroquine sulphate for varied periods of time(43). One group of albino rats was described as receiving 75 mg per kg per day in their feed for periods ranging between 3 and 30 days. The authors did not subsequently discuss the results achieved with this dose group in the cited article. A second group of albino rats received 100 mg per kg per day and were killed after 1, 3, or 21 days on test; and a third group received the same dosage for periods that were variously described as 17 or 18 weeks to 52 weeks. Pigmented rats received the same dosage for a period of 12 months (except the authors also describe results noted after 5 months of medication). Mice received a similar dosage for 11 months. Cats received 50 mg per kg per day in tablets for 2 years, and dogs received 10 mg per kg per day in tablets for periods ranging between 15 and 19 months. MCBs were noted in ganglion cells and their dendrites in the dogs, cats, and mice.
No other evidence of degenerative changes of the retina was described as occurring in these species. In describing the early changes noted in the retina of medicated rats, the changes observed in an albino rat after 5 months (20+ weeks?) of medication are set forth in detail. At this time, MCBs were present in ganglion cells and to a lesser extent in other neural elements of the retina. In addition, dense masses of pleomorphic material (DPM) were present in the cytoplasm of MGller fibers, and membrane-bound vesicles filled with degenerative products were present in the bipolar cells. It was inferred that the retinas of additional albino and pigmented rats were examined after 5 months of medication since the authors stated that, "Abnormal appearances are not seen in the pigment epithelium of either albino or hooded rats a t this stage." In describing the later changes observed in the retinas of medicated rats, the authors describe the changes seen in an albino rat after 17 weeks of medi.cation (less than 5 months).
In this rat, DPM was observed in other cell layers of the retina; and degenerative changes were described as occurring in all layers except for Bruch's membrane. It is not clear from the report if similar changes were noted in other albino or pigmented rats which were medicated for similar periods of time.
In male albino and pigmented rats which have received chloroquine sulphate by stomach tube at a daily dosage of 40 mg per kg dissolved in 0.5 ml of water for periods of 3 months, 3 months followed by a recovery period of 3 months, or 6 months, MCBs were observed in the cytoplasm of retinal bipolar and ganglion cells( 1). These cytoplasmic bodies were described as being in membrane-bound cytoplasmic organelles which were presumed to be lysosomal in nature since the product of an acid phosphatase reaction was partially localized within their membranes. These retinal changes were considered to be irreversible(1) since similar MCBs which form within the hepatocytes of rats which received the same treatment for 3 months followed by a 3-month recovery period disappeared w i t h i n 3 months following the discontinuance of medication(3). In the lattercited study, it was also found that MCBs form within the hepatocytes of rats as early as 6 hours and persist up t o 21 days following a single dose of chloroquine.
In swine which received daily oral medication with an aqueous suspension of chloroquine phosphate a t doses of 25 mg per kg per day for 106 days followed by recovery periods of 1, 6, 34, and 62 days(37,38), 50 mg per kg per day until death which occurred between 32 and 92 days on test(37,38), 75 mg per kg per day until death which occurred between 10 and 14 days on test(811, 100 mg per kg per day until death which occurred between 10 and 14 days on test(81), or 12.5 mg per kg per day for 30 days followed by 100 mg per kg per day until death which occurred between 42 and 47 days on test(37,38), MCBs were observed in neurons of the ganglion cell layer and inner nuclear layers of the retinas(38,81). Many of these cytoplasmic inclusions were described as being membrane bound and " . . .appeared to be lysosomes in the process of partial or complete digestion, or organelle membranes. . . "@I), although the electron micrographs which accompanied the article did not clearly depict such morphology.
In light of the well-documented retinal neuronopathy which may be induced in human beings and a variety of laboratory animals by administration of chloroquine for prolonged periods of time, it seems advisable that in drug safety evaluation studies of compounds which are structurally similar to chloroquine, particular attention should be given to the assessment of any potential ocular toxicity. This is not as simple a matter as it may seem a t first glance. In the clinical evaluation of laboratory animals which have received daily doses of chloroquine for prolonged periods of time, impairment of vision has not been apparent (38) . In such studies with mice, albino and pigmented rats, cats, dogs, and swine(38,43), repeated ophthalmoscopical examination during medication with chloroquine has failed to reveal significant fundal changes related specifically to changes in the neural elements of the retina. It would be desirable to have a test procedure of relatively short duration whereby chloroquine-like compounds could be evaluated for their retinal neuronotoxic effect in laboratory animals. The study reported here was undertaken to develop such a test procedure for the comparison of the retinal neuronotoxic effect of chloroquine phosphate to the effect on the retina produced by medication with GPA-3554, which is a chloroquine-like compound that may be represented by the following structural formula: CH2C02CH3 cx F3C HCI 
MATERIALS A N D METHODS
A total of 67 Charles River albino rats (63dand 49). 6 weeks of age, were utilized i n 4 segments of the study. Rats which received either chloroquine phosphate or GPA-3554 received the compound by gavage as suspensions in a 3% cornstarch vehicle. The treatment schedules were as follows ( Table 2) :
Segment 1: (9d rats) Six rats received daily doses of chloroquine phosphate for a total of 7 consecutive days. Three of the rats received 75 mg/kg of body weight per day, and 3 received 100 mg/kg of body weight per day. The remaining 3 rats were utilized as untreated controls. All rats were killed on the day following the last day of medication.
Segment 2: (8d rats) TWO rats received 150 mg of chloroquine phosphate/kg of body weight per day for 3 consecutive days. Four rats received daily dosages of GPA-3554 for a total of 3 consecutive days. Two of the rats received 75 mg/kg of body weight per day, and 2 received 150 mg/kg of body weight per day. The remaining 2 rats were utilized as untreated controls. All rats were killed on the day following the last day of medication.
Segment 3: (166 and 2 p rats) Seven rats received 150 mg of chloroquine phosphate/kg of body weight per day for 1 (2d). 2 (2d), or 3 (2d and 19) consecutive days. Seven rats received 150 mg of GPA-3554lkg of body weight per day for 1 (23), 2 (24, or 3 (2d and 19) consecutive days. Two male rats received 3% cornstarch for 1 (1 rat) or 3 days (1 rat). The remaining 2 male rats were utilized as untreated controls for 1 (1 rat) or 3 days ( 1 rat). All rats were killed on the day following the last day of their particular period of medication.
Segment 4: (28d and 29 rats) Ten rats received 150 mg of chloroquine phosphate/kg of body weight per day for 1 (3d), 2 (3d), or 3 (3d and 19) consecutive days. The day following the last day of medication, 1 male rat per dose group and the female rat in the 3-day dose group were killed. The remaining animals, 2 males per dose group, were killed following a 30-day period of recovery from medication. Six rats received 150 mg of GPA-3554/kg of body weight per day for 1 (Id), 2 (Id), 3 (Id and 191, or 7 ( 2 4 consecutive days and were killed on the day following the last day of their particular period of medication. Three male rats received 3% cornstarch in their diet for 1 (1 rat), 2 (1 rat), or 3 days (1 rat) and were killed on the day following the last day of their particular period of medication. Eleven male rats were utilized as untreated controls. One rat was killed on day 2, 3, 4, and 8, and two rats were killed on day 32,33, and 34 of the study.
At the time that the rats in each segment were killed, both Segments 1 and 2: An incision was made in the right and left eye of each animal at the time of necropsy, and both eyes were lfixed for 6 to 7 hours in cold (4°C) 3% glutaral$ehyde buffered with Millonigs (340 rn Osm) buffer. After a short preliminary fixation, the lens and vitreous humor were removed from each eye; and a portion of the retina of each eye' was cut into cubes (approximately 1 mm3) and washed overnight in Millonigs buffer. The following day, the cubes of retina from each eye were diced and post-fixed for 1 hour in cold 1% Osmic acid buffered with Millonigs buffer. The diced specimens were subsequently dehydrated in graded acetone and absolute acetone, and embedded in Araldite.
Thick-thin sections (0.5 microns) were prepared of representative embedded retinal specimens of each eye and stained with 1% toluidine blue for bright-field transmission microscopy. Ultra-thin sections (500 to 600 A) were prepared from the same embedded specimens, mounted on copper grids, stained with uranyl acetate and lead citrate, and examined in a Zeiss 9S2 electron microscope.
Segment 3: The left eye of each animal was handled in the same fashion for electron microscopy as described for Segments 1 and 2. At the time of necropsy, the right eye of each animal was divided in half from the optic nerve to the center of the cornea. One half of each eye was fixed in formalin-calcium, and the other half was fixed in Bouin's fluid and subsequently processed as frozen tissue sections as prescribed for Baker's acid hematin test for the histochemical demonstration of phospholipids.
Segment 4: The left eye of each animal which was killed upon the termination of medication was fixed in formalin-calcium, and the right eye was fixed i n Bouin's fluid. Both eyes were subsequently processed as frozen tissue sections as prescribed for Baker's acid hematin test for the histochemical demonstration of phospholipids. The eyes from 1 untreated and 1 treated rat in each recovery group were fixed, processed, and stained in the same fashion as previously described for the demonstration of phospholipids. The eyes of the remaining rats in the recovery groups (1 control and 1 treated per group) were handled in the same fashion for electron microscopy as described for Segments 1 and 2. eyes of each rat were enucleated and processed as follows: 
Chloroquine (1 50) Chloroquine (1 50) Chloroquine * * * One rat sacrificed on days 2,3,4, and 8; two rats sacrificed on days 32, 33, and 34.
One rat sacrificed for each of 1.2. and 3 days, No deviation from normal histological or ultrastructural morphology was observed in the ganglion cell layer of the retina of any of the untreated o r vehicle control rats (Figures  1, 2, and 3) . The typical normal morphology of t h e retina was demonstrated in thick-thin (0.5 micron) sections prepared from tissue embedded in Araldite (Figure 2) . Figure 3 demonstrated the typical normal ultrastructural morphology of the ganglion cell layer of t h e retina of the control rat. The neurons of t h e ganglion cell layer ranged from large to small with considerable variation in t h e density of the 6ytoplasm and nuclei. The majority of neurons had large nuclei with prominent nucleoli, abundant cytoplasm, and numerous dendritic processes. Within t h e cytoplasm of the perikaryon of each neuron, there were prominent granular endoplasmic reticulum which extended into t h e dendritic processes. In the vicinity of t h e endoplasmic reticulum, glycogen granules were readily observed. A few lysosomes were scattered within the perikaryon, and mitrochondria were most readily seen in the vicinity of the endoplasmic reticulum. Numerous vacuoles, interpreted as invaginations of the plasma membrane of the neuron, were seen within t h e perikaryon and the dendrites. Within the lumina of the vacuoles and/or attached to the invaginated plasma membrane, structures interpreted as terminal branchlets of the axons of small bipolar cells of the inner plexiform layer of the retina synapse with the perikaryon and dendritic processes of the ganglion cells. The bases of dense Miiller cells of the inner nuclear layer of the retina were interposed between the ganglion cells. Internally, the ganglion cell layer was bound by the nerve fiber layer of the retina which in turn was bound by a very thin, dense, inner lamina.
Orthochromatic granules (0.5 micron sections stained with toluidine blue) were observed in the neurons of the ganglion cell layer of the retina and in a few of the bipolar cells of the inner nuclear layer by bright-field microscopy of thick-thin sections in all rats treated with chloroquine for 7 and 3 days (Figures 4 and 5) . The granules were more numerous in high-dose rats (150 mg/kg/day) than in low-dose rats (75 mg/kg/day). These granules stain positively with Baker's acid h e m a t i n , indicating a semi-phospholipid o r complete phospholipid composition as previously described by Gregory el al. (43) . No Baker's acid-hematin-positive granules were observed in specimens from any control animal. In the specimens examined by electron microscopy, all normal constituents (as depicted in Figure 3 ) were present within the ganglion cell layer with the exception that relatively few lysosomes were observed within the neuronal cytoplasm ( Figure 6) ; and numerous, small metallophilic, membranous cytoplasmic bodies (MCB), which corresponded to the orthochromatic granules seen by bright-field microscopy, were present in the perinuclear cytoplasm of the perikaryon of most neurons (Figures 6 and 7) . At higher magnification (Figure 8 ), these membranous cytoplasmic bodies (MCB) were seen as oval o r round aggregates of concentrically arranged, closely associated, electron-dense membranes surrounding a finely granular central zone. A few smaller bodies (SMCB) exhibited n o lamination. At even higher magnification (Figure 9) , none of the membranous cytoplasmic bodies were bound by an apparent limiting membrane. The peripheral membrane of the MCB was frequently observed to be continuous with the endoplasmic reticulum (arrows in Figures 9 and 10 ). As seen in Figure 10 , the lamellar membranes of t h e MCB were not evenly spaced throughout but were arranged in layers with t w o electron-dense layers separated by an electron-opaque zone arranged in concentric lamellae around an electron-dense granular zone. Between membrane layers, there was a wider electron-opaque space (designated as "S" in Figure 10 ). No deviation from normal histological o r ultrastructural morphology (Figures 11, 12, and 13) was observed in the ganglion cell layer of the retina of any of the rats which had been medicated with 150 mg/kg/day GPA-3554 for 1, 2, or 3 days. No Baker's acidhematinpositive granules were observed in specimens from animals receiving GPA-3554 for 1, 2,3, or 7 days.
In rats administered 150 mg/kg/day of chloroquine phosphate for 2 days, and to a lesser extent for 1 day, orthochromatic granules were observed by light microscopy in the neurons of the ganglion cell layer of the retina. These orthochromatic granules appeared to be similar to the granules observed in rats administered chloroquine phosphate for 3 and 7 days. However, in these specimens examined by electron microscopy, the metallophilic bodies, which corresponded to t h e orthochromatic granules seen by bright-field microscopy, appeared to be in a presumptive form (PMCB) [Gregory et al. (4311. A few of the granules were typical with concentrically arranged membranes surrounding a granular central zone, and a few exhibited n o lamination; the majority, however, had large, irregular, dense cores with incomplete concentric lamellae a t the periphery. In addition, a few of the granules contained parallel-stacked lamellae (Figures 1 4 and 1 5 -2 days of treatment, Figures 1 6 and 17 -1 day of treatment).
In animals administered chloroquine phosphate (1 50 mg/kg/day for 1, 2, and 3 days) and allowed to recover for 30 days, there was n o deviation from normal histological or ultrastructural morphology (Figure 1 8 -1 day with 30 days' recovery, Figure 1 9 -2 days with 30 days' recovery, Figure 20 -3 days with 30 days' recovery) with one exception.
U l t r a s t r u c t u r a l l y , a n isolated., extra-neuronal area of the ganglion cell layer of t h e retina of 1 animal administered chloroquine for 3 days with 30 days' recovery ( Figure 21 ) r e t a i n e d s o m e of t h e PMCBs previously d e s c r i b e d a n d a darker, more dense appearance than normal of some of the I ysosomes.
DISCUSSION
The deviations from n o r m a l morphology which we observed in t h e ganglion cell layer of the retina by means of both bright-field and electron microscopy of tissue specimens of the eyes of rats treated with either 75 or 1 5 0 mg/kg/day of chloroquine phosphate were essentially identical to those w h i c h h a v e b e e n p r e v i o u s l y d e p i c t e d in t h e literature ( 1,2,4,32-34.42.43.50) .
The morphology of the MCBs ( 1,38,43,50,80,8.1) which we observed as early as 3 days and the PMCBs(43) which we observed as early as 24 hours after t h e administration of a single 150-mg/kg dose of chloroquine phosphate were similar to those which have been depicted as occurring in experimental animals and in a human being which have received more prolonged daily medication with chloroquine. In descriptions which have appeared in the literature, there is some variance of opinion as t o whether MCBs are (1, 43, 81) or are not(43,BO) membrane bound. In the 9 The Bu!letin of the Society of Pharmacological and Environmental Pathologists photog~phs which were used to illustrate the cited articles, we were unable to detect any evidence to indicate that MCBs in the ganglion cells of the retinas of treated experimental animals or the human being were membrane bound. In our own material and in the photographs used to illustrate this article, it is our impression that the MCBs are not membrane bound, i .e., enclosed by a limiting membrane.
Based on the observation that when stained by techniques for the demonstration of sites of acid phosphatase activity the product of the reaction is partially localized within MCBs, some investigators consider MCBs to be altered Iysosomes(l,81), However, lysosomes are not the only sites of acid phosphatase activity in the retina of rats(l,4). In some instances, the endoplasmic reticulum of the retinal cells of rats has been observed to contain sites of acid phosphatase activity(l,4). We did not employ techniques for the demonstration of acid phosphatase activity, but we did observe that the outer lamellae of MCBs frequently appeared to be continuous with the endoplasmic reticulum, suggesting that they were either derived from or were expressions of some structural modification of the endoplasmic reticulum. Such an origin could account for sites of acid phosphatase activity within MCBs(l,4). That MCBs are possibly derived from the endoplasmic reticulum has also been suggested by Gregory el al. (43) .
The formation of MCBs and PMCBs in the retina of rats which have received medication with chloroquine have been reported to be irreversible(1). In the cited study, the period of medication extended over a period of 3 months, Our results suggest that, although PMCBs and MCBs are seen within the ganglion cells of rats after 3 days of medication at a dosage of 150 mg/kg/day, these changes are reversible within 30 days if the treatment is discontinued by the third day of medication. This observation i s of interest in light of several reports (22, 26) concerning cases of chloroquine retinopathy in human beings in which it was suggested that, if the retinopathy is recognized in its very early stages and treatment i s immediately dis~ontinued, it may be reversible.
From our test with GPA-3554, it was readily apparent that this chloroquine-like compound did not produce any retinal lesion when administer~d to rats for 1, 2, 3, or 7 days a t the same dosage as chloroquine. A gangliopathy of the retina was apparent in all rats which received 'chloroquine as early as the f i r s t day after medication, The chloroquine-induced retinal gangliopathy progressed in severity as medication was continued. Although, based on its formula, one might expect GPA-3554 to produce a ~ngliopathy, the negative results of this study were corroborated by negative results obtained in a previous 30-day oral toxicity study (not reported here) in albino rats (150 mg/kg/day maximal dose).
It was also apparent that although electron microscopy was an interesting means of studying the chloroquine-induced retinopathy in rats, it was not essential to our ability to detect the gangliopathy. The granular, acidophilic, intracytoplasmic bodies which form within the ganglion cells of chloroquine-treated (1 50 mg/kg/day) rats can be readily detected in paraffin-embedded tissue sections of the retina when stained with hematoxylin and eosin and examined by conventional bright-field microscopyf37).
We are of the opinion that the study reported here provides a useful test system for the initial acute evaluation of any chloroquine-like compound. By utilizing chloroquine (150 mg/kg/day) as the positive control, one should be able to determine within 3 days i f the chloroquine-like test compound does or does not produce a gangliopathy of the retina as determined by routine histologic procedures. I f the test compound does produce a gangliopathy, further acute or chronic toxicity studies might not be warranted. If it does not produce an acute gangliopathy, the prospect for further evaluation in long-term studies is at least brighter. This is particularly true if one keeps in mind that in the commonly used species of laboratory animals a chloroquine-like gangliopathy of the retina may exist for periods which exceed the duration of 6-month toxicity studies and provides no clinical evidence of i t s existence even upon repeated ophthalmoscopicat examination during medication (38,431. ' I 4 f -c a Fig. 1 This print is included for general orientation. The alpha-numeric overprinting on this figure refers to the layers of the retina as follows: a = Sclera b = Choroid c = Retina , . Normal histologic morphology as observed by bright-field microscopy in thick-thin (0.5 micron) tissue sections prepared from the same embedded tissue specimen from which 600 A sections were cut of the ganglion cell layer for electron microscopy (400 X).
Fig. 4-5
Orthochromatic granules in the cytoplasm of neurons of the ganglion cell layer observed by bright-field microscopy of thick-thin sections in rats treated with chloroquine, 150 mglkglday for 7 days and 75 ~g l k g l d a y for 7 days (400 XI (250 X). The numeric legends relate to the retinal layers denoted in Fig. 1 and 2.
Fig. 5
Fig. 6 Numerous, small, metallophilic membranous cytoplasmic bodies (MCB) which correspond to the orthochromatic granules seen by bright-field microscopy are present in the perinuclear cytoplasm of the perikaryon of each neuron (arrows) from rats treated with chloroquine, 150 mg/kg/day for 7 days (1,900 XI. Fig. 7 .
Metallophilic membranous cytoplasmic bodies as described in Figure 6 are also observed in nwronal cells from the ganglion cell layer of a rat administered chloroquine phosphate 75 rng/kg/day for 7 days (4.700 X). 
20
. Fig. 12 Figs. 11-13 No MCB are observed in the ganglion cell layer of the retina of rats which had been medicated with 150 mglkglday GPA-3554 for 1, 2, or 3 days (4,700 X). . .
,. 20
See page 23 for legend.
Fig. 21
Extra-neuronal PMCB in a single isolated area of the retina of a rat which was administered chloroquine phosphate 150 mg/kg/day for 3 days and allowed to recover for 30 days (1,900 XI.
